110863,1,Admission,O
110863,1,Date,O
110863,1,:,O
110863,1,[,O
110863,1,**2108-12-11**,O
110863,1,],O
110863,1,Discharge,O
110863,1,Date,O
110863,1,:,O
110863,1,[,O
110863,1,**2108-12-16**,O
110863,1,],O
110863,1,Service,O
110863,1,:,O
110863,1,MEDICINE,O
110863,1,Allergies,O
110863,1,:,O
110863,1,Niacin,B-Drug
110863,1,Attending,O
110863,1,:,O
110863,1,[,O
110863,1,**First,O
110863,1,Name3,O
110863,1,(,O
110863,1,LF,O
110863,1,),O
110863,1,2024**,O
110863,1,],O
110863,1,Chief,O
110863,1,Complaint,O
110863,1,:,O
110863,1,generalized,O
110863,1,weakness,O
110863,1,",",O
110863,1,odynophagia,O
110863,1,Major,O
110863,1,Surgical,O
110863,1,or,O
110863,1,Invasive,O
110863,1,Procedure,O
110863,1,:,O
110863,1,HD,O
110863,1,History,O
110863,1,of,O
110863,1,Present,O
110863,1,Illness,O
110863,1,:,O
110863,1,85-year-old,O
110863,1,man,O
110863,1,with,O
110863,1,a,O
110863,1,history,O
110863,1,of,O
110863,1,recently,O
110863,1,diagnosed,O
110863,1,Kaposi's,O
110863,1,sarcoma,O
110863,1,with,O
110863,1,visceral,O
110863,1,involvement,O
110863,1,",",O
110863,1,duodenal,O
110863,1,ulcer,O
110863,1,",",O
110863,1,ESRD,O
110863,1,not,O
110863,1,on,O
110863,1,HD,O
110863,1,",",O
110863,1,HTN,O
110863,1,",",O
110863,1,HL,O
110863,1,",",O
110863,1,sCHF,O
110863,1,w/EF,O
110863,1,40,O
110863,1,%,O
110863,1,",",O
110863,1,recent,O
110863,1,admission,O
110863,1,for,O
110863,1,GIB,O
110863,1,",",O
110863,1,is,O
110863,1,transferred,O
110863,1,here,O
110863,1,from,O
110863,1,OSH,O
110863,1,for,O
110863,1,generalized,O
110863,1,weakness,O
110863,1,",",O
110863,1,confusion,O
110863,1,",",O
110863,1,odynophagia,O
110863,1,.,O
110863,1,.,O
110863,1,Patient,O
110863,1,received,O
110863,1,his,O
110863,1,cycle,O
110863,1,2,O
110863,1,of,O
110863,1,paclitaxel,B-Drug
110863,1,on,O
110863,1,[,O
110863,1,**2108-12-5**,O
110863,1,],O
110863,1,and,O
110863,1,has,O
110863,1,been,O
110863,1,experiencing,O
110863,1,odynophagia,O
110863,1,from,O
110863,1,mucositis,O
110863,1,.,O
110863,1,For,O
110863,1,the,O
110863,1,past,O
110863,1,few,O
110863,1,days,O
110863,1,he,O
110863,1,has,O
110863,1,felt,O
110863,1,``,O
110863,1,not,O
110863,1,well,O
110863,1,'',O
110863,1,at,O
110863,1,home,O
110863,1,",",O
110863,1,complaining,O
110863,1,of,O
110863,1,intermittent,O
110863,1,shortness,O
110863,1,of,O
110863,1,breath,O
110863,1,",",O
110863,1,odynophagia,O
110863,1,and,O
110863,1,dysphagia,O
110863,1,.,O
110863,1,He,O
110863,1,presented,O
110863,1,to,O
110863,1,[,O
110863,1,**Hospital6,O
110863,1,10353**,O
110863,1,],O
110863,1,on,O
110863,1,[,O
110863,1,**2108-12-10**,O
110863,1,],O
110863,1,.,O
110863,1,There,O
110863,1,",",O
110863,1,he,O
110863,1,was,O
110863,1,found,O
110863,1,to,O
110863,1,have,O
110863,1,pancytopenia,O
110863,1,.,O
110863,1,Initially,O
110863,1,CHF,O
110863,1,exacerbation,O
110863,1,was,O
110863,1,suspected,O
110863,1,given,O
110863,1,clinical,O
110863,1,status,O
110863,1,and,O
110863,1,BNP,O
110863,1,of,O
110863,1,"65,987",O
110863,1,.,O
110863,1,However,O
110863,1,",",O
110863,1,chest,O
110863,1,CT,O
110863,1,without,O
110863,1,contrast,O
110863,1,showed,O
110863,1,moderate,O
110863,1,pleural,O
110863,1,effusion,O
110863,1,with,O
110863,1,right,O
110863,1,lower,O
110863,1,lobe,O
110863,1,atelectasis,O
110863,1,",",O
110863,1,but,O
110863,1,no,O
110863,1,evidence,O
110863,1,of,O
110863,1,pulmonary,O
110863,1,edema,O
110863,1,.,O
110863,1,Pneumonia,B-Reason
110863,1,was,O
110863,1,suspected,O
110863,1,and,O
110863,1,patient,O
110863,1,was,O
110863,1,started,O
110863,1,on,O
110863,1,ceftriaxone,B-Drug
110863,1,and,O
110863,1,vancomycin,B-Drug
110863,1,.,O
110863,1,His,O
110863,1,home,O
110863,1,furosemide,B-Drug
110863,1,was,O
110863,1,held,O
110863,1,.,O
110863,1,.,O
110863,1,While,O
110863,1,at,O
110863,1,[,O
110863,1,**Hospital6,O
110863,1,10353**,O
110863,1,],O
110863,1,",",O
110863,1,patient,O
110863,1,started,O
110863,1,to,O
110863,1,be,O
110863,1,delirious,O
110863,1,",",O
110863,1,not,O
110863,1,knowing,O
110863,1,where,O
110863,1,he,O
110863,1,was,O
110863,1,",",O
110863,1,attempting,O
110863,1,to,O
110863,1,get,O
110863,1,out,O
110863,1,of,O
110863,1,bed,O
110863,1,frequently,O
110863,1,",",O
110863,1,and,O
110863,1,at,O
110863,1,one,O
110863,1,point,O
110863,1,falling,O
110863,1,without,O
110863,1,head,O
110863,1,trauma,O
110863,1,",",O
110863,1,per,O
110863,1,his,O
110863,1,family,O
110863,1,.,O
110863,1,At,O
110863,1,OSH,O
110863,1,",",O
110863,1,hct,O
110863,1,23,O
110863,1,and,O
110863,1,plts,O
110863,1,35,O
110863,1,.,O
110863,1,His,O
110863,1,CXR,O
110863,1,showed,O
110863,1,bilateral,O
110863,1,pleural,O
110863,1,effusions,O
110863,1,.,O
110863,1,He,O
110863,1,was,O
110863,1,started,O
110863,1,on,O
110863,1,ceftriaxone,B-Drug
110863,1,and,O
110863,1,vancomycin,B-Drug
110863,1,empirically,O
110863,1,.,O
110863,1,.,O
110863,1,Review,O
110863,1,of,O
110863,1,Systems,O
110863,1,:,O
110863,1,(,O
110863,1,+,O
110863,1,),O
110863,1,Per,O
110863,1,HPI,O
110863,1,(,O
110863,1,-,O
110863,1,),O
110863,1,Denies,O
110863,1,fever,O
110863,1,",",O
110863,1,chills,O
110863,2,",",O
110863,2,night,O
110863,2,sweats,O
110863,2,",",O
110863,2,recent,O
110863,2,weight,O
110863,2,loss,O
110863,2,or,O
110863,2,gain,O
110863,2,.,O
110863,2,Denies,O
110863,2,blurry,O
110863,2,vision,O
110863,2,",",O
110863,2,diplopia,O
110863,2,",",O
110863,2,loss,O
110863,2,of,O
110863,2,vision,O
110863,2,",",O
110863,2,photophobia,O
110863,2,.,O
110863,2,Denies,O
110863,2,headache,O
110863,2,",",O
110863,2,sinus,O
110863,2,tenderness,O
110863,2,",",O
110863,2,rhinorrhea,O
110863,2,or,O
110863,2,congestion,O
110863,2,.,O
110863,2,Denies,O
110863,2,chest,O
110863,2,pain,O
110863,2,or,O
110863,2,tightness,O
110863,2,",",O
110863,2,palpitations,O
110863,2,",",O
110863,2,lower,O
110863,2,extremity,O
110863,2,edema,O
110863,2,.,O
110863,2,Denies,O
110863,2,cough,O
110863,2,",",O
110863,2,shortness,O
110863,2,of,O
110863,2,breath,O
110863,2,",",O
110863,2,or,O
110863,2,wheezes,O
110863,2,.,O
110863,2,Denies,O
110863,2,nausea,O
110863,2,",",O
110863,2,vomiting,O
110863,2,",",O
110863,2,diarrhea,O
110863,2,",",O
110863,2,constipation,O
110863,2,",",O
110863,2,abdominal,O
110863,2,pain,O
110863,2,",",O
110863,2,melena,O
110863,2,",",O
110863,2,hematemesis,O
110863,2,",",O
110863,2,hematochezia,O
110863,2,.,O
110863,2,Denies,O
110863,2,abnormal,O
110863,2,bleeding,O
110863,2,",",O
110863,2,bruising,O
110863,2,",",O
110863,2,lymphadenopathy,O
110863,2,.,O
110863,2,Denies,O
110863,2,dysuria,O
110863,2,",",O
110863,2,stool,O
110863,2,or,O
110863,2,urine,O
110863,2,incontinence,O
110863,2,.,O
110863,2,Denies,O
110863,2,arthralgias,O
110863,2,or,O
110863,2,myalgias,O
110863,2,.,O
110863,2,Denies,O
110863,2,rashes,O
110863,2,or,O
110863,2,skin,O
110863,2,breakdown,O
110863,2,.,O
110863,2,No,O
110863,2,numbness/tingling,O
110863,2,in,O
110863,2,extremities,O
110863,2,.,O
110863,2,All,O
110863,2,other,O
110863,2,systems,O
110863,2,negative,O
110863,2,.,O
110863,2,Past,O
110863,2,Medical,O
110863,2,History,O
110863,2,:,O
110863,2,Past,O
110863,2,Oncologic,O
110863,2,History,O
110863,2,:,O
110863,2,Kaposi,O
110863,2,'s,O
110863,2,sarcoma,O
110863,2,diagnosed,O
110863,2,by,O
110863,2,LLE,O
110863,2,biopsy,O
110863,2,[,O
110863,2,**2108-10-23**,O
110863,2,],O
110863,2,by,O
110863,2,dermatology,O
110863,2,;,O
110863,2,evidence,O
110863,2,of,O
110863,2,visceral,O
110863,2,involvement,O
110863,2,on,O
110863,2,GI,O
110863,2,capsule,O
110863,2,study,O
110863,2,[,O
110863,2,**2108-10-30**,O
110863,2,],O
110863,2,.,O
110863,2,Admitted,O
110863,2,by,O
110863,2,Dr.,O
110863,2,[,O
110863,2,**First,O
110863,2,Name8,O
110863,2,(,O
110863,2,NamePattern2,O
110863,2,),O
110863,2,916**,O
110863,2,],O
110863,2,[,O
110863,2,**Last,O
110863,2,Name,O
110863,2,(,O
110863,2,NamePattern1,O
110863,2,),O
110863,2,**,O
110863,2,],O
110863,2,on,O
110863,2,[,O
110863,2,**2108-11-14**,O
110863,2,],O
110863,2,for,O
110863,2,cycle,O
110863,2,1,O
110863,2,of,O
110863,2,Taxol,B-Drug
110863,2,.,O
110863,2,.,O
110863,2,Other,O
110863,2,Past,O
110863,2,Medical,O
110863,2,History,O
110863,2,:,O
110863,2,Upper,O
110863,2,GI,O
110863,2,bleed,O
110863,2,though,O
110863,2,secondary,O
110863,2,to,O
110863,2,Dieulafoy,O
110863,2,'s,O
110863,2,lesion,O
110863,2,ESRD,O
110863,2,with,O
110863,2,right,O
110863,2,sided,O
110863,2,AV,O
110863,2,fistula,O
110863,2,",",O
110863,2,not,O
110863,2,on,O
110863,2,HD,O
110863,2,CAD,O
110863,2,s/p,O
110863,2,CABGx3,O
110863,2,in,O
110863,2,[,O
110863,2,**2095**,O
110863,2,],O
110863,2,",",O
110863,2,s/p,O
110863,2,SVG,O
110863,2,to,O
110863,2,RCA,O
110863,2,stent,O
110863,2,[,O
110863,2,**2099**,O
110863,2,],O
110863,2,",",O
110863,2,SVG,O
110863,2,to,O
110863,2,OM,O
110863,2,stent,O
110863,2,[,O
110863,2,**2106**,O
110863,2,],O
110863,2,.,O
110863,2,Recent,O
110863,2,p-mibi,O
110863,2,with,O
110863,2,moderate,O
110863,2,ischemia,O
110863,2,in,O
110863,2,anterior,O
110863,2,wall,O
110863,2,in,O
110863,2,[,O
110863,2,**6-7**,O
110863,2,],O
110863,2,",",O
110863,2,cath,O
110863,2,deferred,O
110863,2,due,O
110863,2,to,O
110863,2,renal,O
110863,2,function,O
110863,2,.,O
110863,2,CHF,O
110863,2,",",O
110863,2,chronic,O
110863,2,systolic,O
110863,2,and,O
110863,2,diastolic,O
110863,2,",",O
110863,2,EF,O
110863,2,40,O
110863,2,%,O
110863,2,on,O
110863,2,recent,O
110863,2,P-mibi,O
110863,2,Moderate,O
110863,2,Aortic,O
110863,2,stenosis,O
110863,2,Anemia,O
110863,2,Hearing,O
110863,2,impairment,O
110863,2,Right,O
110863,2,AV,O
110863,2,fistula,O
110863,2,placed,O
110863,2,[,O
110863,2,**2108-5-21**,O
110863,2,],O
110863,2,Hyperparathyroidism,O
110863,2,due,O
110863,2,to,O
110863,2,ESRD,O
110863,2,Obesity,O
110863,2,HTN,O
110863,2,HL,O
110863,2,BPH,O
110863,2,Intraocular,O
110863,2,lens,O
110863,2,Social,O
110863,2,History,O
110863,2,:,O
110863,2,Lives,O
110863,2,at,O
110863,2,home,O
110863,2,on,O
110863,2,[,O
110863,2,**Location,O
110863,2,(,O
110863,2,un,O
110863,2,),O
110863,2,448**,O
110863,2,],O
110863,2,of,O
110863,2,home,O
110863,2,with,O
110863,2,wife,O
110863,2,who,O
110863,2,has,O
110863,2,early,O
110863,2,[,O
110863,2,**Name,O
110863,3,(,O
110863,3,NI,O
110863,3,),O
110863,3,11964**,O
110863,3,],O
110863,3,.,O
110863,3,Has,O
110863,3,a,O
110863,3,caretaker,O
110863,3,who,O
110863,3,is,O
110863,3,in,O
110863,3,every,O
110863,3,other,O
110863,3,day,O
110863,3,to,O
110863,3,help,O
110863,3,with,O
110863,3,medications,O
110863,3,",",O
110863,3,appointments,O
110863,3,.,O
110863,3,Previously,O
110863,3,worked,O
110863,3,for,O
110863,3,local,O
110863,3,school,O
110863,3,system,O
110863,3,",",O
110863,3,fought,O
110863,3,in,O
110863,3,the,O
110863,3,infantry,O
110863,3,in,O
110863,3,WWII,O
110863,3,in,O
110863,3,[,O
110863,3,**Country,O
110863,3,480**,O
110863,3,],O
110863,3,and,O
110863,3,in,O
110863,3,[,O
110863,3,**Country,O
110863,3,2559**,O
110863,3,],O
110863,3,.,O
110863,3,Distant,O
110863,3,history,O
110863,3,of,O
110863,3,tobacco,O
110863,3,use,O
110863,3,60,O
110863,3,years,O
110863,3,ago,O
110863,3,",",O
110863,3,1ppd,O
110863,3,for,O
110863,3,2,O
110863,3,years,O
110863,3,",",O
110863,3,denies,O
110863,3,EtOH,O
110863,3,and,O
110863,3,illicit,O
110863,3,drug,O
110863,3,use,O
110863,3,.,O
110863,3,Family,O
110863,3,History,O
110863,3,:,O
110863,3,Sister,O
110863,3,w/brain,O
110863,3,CA,O
110863,3,",",O
110863,3,brother,O
110863,3,w/,O
110863,3,[,O
110863,3,**Name2,O
110863,3,(,O
110863,3,NI,O
110863,3,),O
110863,3,499**,O
110863,3,],O
110863,3,CA,O
110863,3,",",O
110863,3,both,O
110863,3,deceased,O
110863,3,.,O
110863,3,Brother,O
110863,3,died,O
110863,3,of,O
110863,3,sudden,O
110863,3,cardiac,O
110863,3,death,O
110863,3,at,O
110863,3,age,O
110863,3,56,O
110863,3,.,O
110863,3,Father,O
110863,3,died,O
110863,3,at,O
110863,3,age,O
110863,3,80,O
110863,3,of,O
110863,3,?,O
110863,3,CVA,O
110863,3,.,O
110863,3,Mother,O
110863,3,died,O
110863,3,of,O
110863,3,[,O
110863,3,**Name,O
110863,3,(,O
110863,3,NI,O
110863,3,),O
110863,3,5895**,O
110863,3,],O
110863,3,in,O
110863,3,her,O
110863,3,80,O
110863,3,'s,O
110863,3,.,O
110863,3,Physical,O
110863,3,Exam,O
110863,3,:,O
110863,3,VS,O
110863,3,:,O
110863,3,T,O
110863,3,99.1,O
110863,3,",",O
110863,3,BP,O
110863,3,122/70,O
110863,3,",",O
110863,3,HR,O
110863,3,78,O
110863,3,",",O
110863,3,RR,O
110863,3,24,O
110863,3,",",O
110863,3,98,O
110863,3,%,O
110863,3,RA,O
110863,3,GEN,O
110863,3,:,O
110863,3,Elderly,O
110863,3,man,O
110863,3,in,O
110863,3,NAD,O
110863,3,",",O
110863,3,awake,O
110863,3,HEENT,O
110863,3,:,O
110863,3,EOMI,O
110863,3,",",O
110863,3,PERRL,O
110863,3,",",O
110863,3,sclera,O
110863,3,anicteric,O
110863,3,",",O
110863,3,conjunctivae,O
110863,3,clear,O
110863,3,",",O
110863,3,OP,O
110863,3,moist,O
110863,3,and,O
110863,3,without,O
110863,3,lesion,O
110863,3,NECK,O
110863,3,:,O
110863,3,Supple,O
110863,3,",",O
110863,3,no,O
110863,3,JVD,O
110863,3,CV,O
110863,3,:,O
110863,3,Reg,O
110863,3,rate,O
110863,3,",",O
110863,3,normal,O
110863,3,S1,O
110863,3,",",O
110863,3,S2,O
110863,3,.,O
110863,3,No,O
110863,3,m/r/g,O
110863,3,.,O
110863,3,CHEST,O
110863,3,:,O
110863,3,Resp,O
110863,3,were,O
110863,3,unlabored,O
110863,3,",",O
110863,3,no,O
110863,3,accessory,O
110863,3,muscle,O
110863,3,use,O
110863,3,.,O
110863,3,Bibasilar,O
110863,3,crackles,O
110863,3,R,O
110863,3,>,O
110863,3,L,O
110863,3,",",O
110863,3,scattered,O
110863,3,expiratory,O
110863,3,wheezes,O
110863,3,ABD,O
110863,3,:,O
110863,3,Soft,O
110863,3,",",O
110863,3,NT,O
110863,3,",",O
110863,3,ND,O
110863,3,",",O
110863,3,no,O
110863,3,HSM,O
110863,3,",",O
110863,3,bowel,O
110863,3,sounds,O
110863,3,present,O
110863,3,MSK,O
110863,3,:,O
110863,3,normal,O
110863,3,muscle,O
110863,3,tone,O
110863,3,and,O
110863,3,bulk,O
110863,3,EXT,O
110863,3,:,O
110863,3,1+,O
110863,3,bilateraly,O
110863,3,LE,O
110863,3,edema,O
110863,3,to,O
110863,3,mid-shin,O
110863,3,",",O
110863,3,2+,O
110863,3,DP/PT,O
110863,3,bilaterally,O
110863,3,SKIN,O
110863,3,:,O
110863,3,No,O
110863,3,rash,O
110863,3,",",O
110863,3,warm,O
110863,3,skin,O
110863,3,NEURO,O
110863,3,:,O
110863,3,oriented,O
110863,3,to,O
110863,3,name,O
110863,3,",",O
110863,3,``,O
110863,3,hospital,O
110863,3,",",O
110863,3,'',O
110863,3,but,O
110863,3,not,O
110863,3,date,O
110863,3,;,O
110863,3,answered,O
110863,3,'',O
110863,3,[,O
110863,3,**Doctor,O
110863,3,First,O
110863,3,Name,O
110863,3,4375**,O
110863,3,],O
110863,3,'',O
110863,3,for,O
110863,3,US,O
110863,3,president,O
110863,3,;,O
110863,3,normal,O
110863,3,attention,O
110863,3,but,O
110863,3,hard,O
110863,3,of,O
110863,3,hearing,O
110863,3,;,O
110863,3,CN,O
110863,3,II-XII,O
110863,3,intact,O
110863,3,",",O
110863,3,5/5,O
110863,3,strength,O
110863,3,throughout,O
110863,3,but,O
110863,3,exam,O
110863,3,not,O
110863,3,accurate,O
110863,3,due,O
110863,3,to,O
110863,3,patient,O
110863,3,'s,O
110863,3,not,O
110863,3,fully,O
110863,3,cooperating,O
110863,3,",",O
110863,4,intact,O
110863,4,sensation,O
110863,4,to,O
110863,4,light,O
110863,4,touch,O
110863,4,PSYCH,O
110863,4,:,O
110863,4,slightly,O
110863,4,confused,O
110863,4,",",O
110863,4,asking,O
110863,4,family,O
110863,4,members,O
110863,4,about,O
110863,4,non-relevant,O
110863,4,things,O
110863,4,LYMPH,O
110863,4,:,O
110863,4,no,O
110863,4,cervical,O
110863,4,",",O
110863,4,axillary,O
110863,4,",",O
110863,4,inguinal,O
110863,4,LAD,O
110863,4,Pertinent,O
110863,4,Results,O
110863,4,:,O
110863,4,[,O
110863,4,**2108-12-12**,O
110863,4,],O
110863,4,12:08AM,O
110863,4,BLOOD,O
110863,4,WBC-0.3*,O
110863,4,#,O
110863,4,RBC-3.17*,O
110863,4,Hgb-9.2*,O
110863,4,Hct-26.0*,O
110863,4,MCV-82,O
110863,4,MCH-29.1,O
110863,4,MCHC-35.4*,O
110863,4,RDW-16.7*,O
110863,4,Plt,O
110863,4,Ct-47*,O
110863,4,#,O
110863,4,[,O
110863,4,**2108-12-12**,O
110863,4,],O
110863,4,12:08AM,O
110863,4,BLOOD,O
110863,4,Plt,O
110863,4,Ct-47*,O
110863,4,#,O
110863,4,[,O
110863,4,**2108-12-12**,O
110863,4,],O
110863,4,12:08AM,O
110863,4,BLOOD,O
110863,4,PT-13.7*,O
110863,4,PTT-26.8,O
110863,4,INR,O
110863,4,(,O
110863,4,PT,O
110863,4,),O
110863,4,-1.2*,O
110863,4,[,O
110863,4,**2108-12-12**,O
110863,4,],O
110863,4,12:08AM,O
110863,4,BLOOD,O
110863,4,Glucose-118*,O
110863,4,UreaN-133*,O
110863,4,Creat-4.1*,O
110863,4,Na-144,O
110863,4,K-4.3,O
110863,4,Cl-105,O
110863,4,HCO3-24,O
110863,4,AnGap-19,O
110863,4,.,O
110863,4,IMAGING,O
110863,4,:,O
110863,4,#,O
110863,4,Chest,O
110863,4,CT,O
110863,4,(,O
110863,4,OSH,O
110863,4,),O
110863,4,moderate,O
110863,4,R,O
110863,4,pleural,O
110863,4,effusion,O
110863,4,with,O
110863,4,RLL,O
110863,4,atelectasis,O
110863,4,#,O
110863,4,CXR,O
110863,4,[,O
110863,4,**12-14**,O
110863,4,],O
110863,4,:,O
110863,4,FINDINGS,O
110863,4,:,O
110863,4,In,O
110863,4,comparison,O
110863,4,with,O
110863,4,the,O
110863,4,study,O
110863,4,of,O
110863,4,[,O
110863,4,**12-12**,O
110863,4,],O
110863,4,",",O
110863,4,there,O
110863,4,is,O
110863,4,layering,O
110863,4,of,O
110863,4,substantial,O
110863,4,right,O
110863,4,pleural,O
110863,4,effusion,O
110863,4,.,O
110863,4,Probably,O
110863,4,smaller,O
110863,4,left,O
110863,4,pleural,O
110863,4,effusion,O
110863,4,shows,O
110863,4,layering,O
110863,4,as,O
110863,4,well,O
110863,4,.,O
110863,4,Continued,O
110863,4,enlargement,O
110863,4,of,O
110863,4,the,O
110863,4,cardiac,O
110863,4,silhouette,O
110863,4,with,O
110863,4,evidence,O
110863,4,of,O
110863,4,pulmonary,O
110863,4,vascular,O
110863,4,congestion,O
110863,4,.,O
110863,4,Underlying,O
110863,4,lungs,O
110863,4,are,O
110863,4,difficult,O
110863,4,to,O
110863,4,evaluate,O
110863,4,",",O
110863,4,though,O
110863,4,there,O
110863,4,are,O
110863,4,probably,O
110863,4,at,O
110863,4,least,O
110863,4,atelectatic,O
110863,4,changes,O
110863,4,at,O
110863,4,both,O
110863,4,bases,O
110863,4,.,O
110863,4,#,O
110863,4,CXR,O
110863,4,[,O
110863,4,**12-12**,O
110863,4,],O
110863,4,:,O
110863,4,IMPRESSION,O
110863,4,:,O
110863,4,Findings,O
110863,4,suggestive,O
110863,4,of,O
110863,4,a,O
110863,4,pleural,O
110863,4,effusion,O
110863,4,on,O
110863,4,the,O
110863,4,right,O
110863,4,with,O
110863,4,opacities,O
110863,4,that,O
110863,4,can,O
110863,4,likely,O
110863,4,be,O
110863,4,attributed,O
110863,4,to,O
110863,4,atelectasis,O
110863,4,.,O
110863,4,Pneumonia,O
110863,4,can,O
110863,4,not,O
110863,4,be,O
110863,4,completely,O
110863,4,excluded,O
110863,4,",",O
110863,4,however,O
110863,4,.,O
110863,4,Follow-up,O
110863,4,radiographs,O
110863,4,may,O
110863,4,be,O
110863,4,helpful,O
110863,4,for,O
110863,4,continued,O
110863,4,evaluation,O
110863,4,.,O
110863,4,Brief,O
110863,4,Hospital,O
110863,4,Course,O
110863,4,:,O
110863,4,85-year-old,O
110863,4,man,O
110863,4,with,O
110863,4,Kaposi,O
110863,4,'s,O
110863,4,sarcoma,O
110863,4,with,O
110863,4,visceral,O
110863,4,involvement,O
110863,4,",",O
110863,4,CHF,O
110863,4,",",O
110863,4,CKD,O
110863,4,presents,O
110863,4,with,O
110863,4,confusion,O
110863,4,",",O
110863,4,dyspnea,O
110863,4,",",O
110863,4,odynophagia,O
110863,4,",",O
110863,4,generalized,O
110863,4,weakness,O
110863,4,.,O
110863,4,.,O
110863,4,#,O
110863,4,.,O
110863,4,Goals,O
110863,4,of,O
110863,4,Care,O
110863,4,:,O
110863,4,Patient,O
110863,4,was,O
110863,4,transferred,O
110863,4,to,O
110863,4,the,O
110863,4,ICU,O
110863,4,for,O
110863,4,hypoxia,O
110863,4,to,O
110863,4,the,O
110863,4,high,O
110863,4,80s,O
110863,4,from,O
110863,4,pulmonary,O
110863,4,edema,O
110863,4,and,O
110863,4,the,O
110863,4,plan,O
110863,4,to,O
110863,4,initiate,O
110863,4,dialysis,O
110863,4,to,O
110863,4,remove,O
110863,4,fluid,O
110863,4,.,O
110863,4,The,O
110863,4,patient,O
110863,4,did,O
110863,4,receive,O
110863,4,one,O
110863,4,round,O
110863,4,of,O
110863,4,dialysis,O
110863,4,before,O
110863,4,he,O
110863,4,and,O
110863,4,his,O
110863,4,family,O
110863,4,decided,O
110863,4,to,O
110863,4,change,O
110863,4,his,O
110863,4,goals,O
110863,4,of,O
110863,4,care,O
110863,4,.,O
110863,4,While,O
110863,4,in,O
110863,4,the,O
110863,4,ICU,O
110863,4,",",O
110863,4,it,O
110863,4,was,O
110863,4,decided,O
110863,4,that,O
110863,4,the,O
110863,4,patient,O
110863,5,would,O
110863,5,be,O
110863,5,made,O
110863,5,comfort,O
110863,5,measures,O
110863,5,only,O
110863,5,.,O
110863,5,The,O
110863,5,patient,O
110863,5,was,O
110863,5,started,O
110863,5,on,O
110863,5,a,O
110863,5,Morphine,B-Drug
110863,5,drip,O
110863,5,",",O
110863,5,Benadryl,B-Drug
110863,5,for,O
110863,5,itching,B-Reason
110863,5,related,I-Reason
110863,5,uremia,I-Reason
110863,5,",",O
110863,5,and,O
110863,5,Haldol,B-Drug
110863,5,for,O
110863,5,terminal,B-Reason
110863,5,delirium,I-Reason
110863,5,.,O
110863,5,The,O
110863,5,patient,O
110863,5,was,O
110863,5,subsequently,O
110863,5,transfered,O
110863,5,to,O
110863,5,the,O
110863,5,oncology,O
110863,5,inpatient,O
110863,5,service,O
110863,5,.,O
110863,5,Pt,O
110863,5,expired,O
110863,5,the,O
110863,5,following,O
110863,5,night,O
110863,5,.,O
110863,5,.,O
110863,5,#,O
110863,5,.,O
110863,5,Dyspnea,O
110863,5,:,O
110863,5,Patient,O
110863,5,presented,O
110863,5,with,O
110863,5,some,O
110863,5,wheezing,O
110863,5,on,O
110863,5,exam,O
110863,5,",",O
110863,5,bilateral,O
110863,5,crackles,O
110863,5,R,O
110863,5,>,O
110863,5,L,O
110863,5,.,O
110863,5,CT,O
110863,5,showed,O
110863,5,right-sided,O
110863,5,pleural,O
110863,5,effusion,O
110863,5,.,O
110863,5,Intermittently,O
110863,5,tachypneic,O
110863,5,but,O
110863,5,with,O
110863,5,good,O
110863,5,O2,O
110863,5,saturation,O
110863,5,.,O
110863,5,There,O
110863,5,is,O
110863,5,no,O
110863,5,clear,O
110863,5,evidence,O
110863,5,of,O
110863,5,pneumonia,O
110863,5,.,O
110863,5,Patient,O
110863,5,does,O
110863,5,not,O
110863,5,have,O
110863,5,significant,O
110863,5,coughs,O
110863,5,and,O
110863,5,the,O
110863,5,chest,O
110863,5,CT,O
110863,5,showed,O
110863,5,no,O
110863,5,clear,O
110863,5,infiltrate,O
110863,5,.,O
110863,5,Antibiotics,B-Drug
110863,5,were,O
110863,5,discontinued,O
110863,5,on,O
110863,5,the,O
110863,5,oncology,O
110863,5,service,O
110863,5,.,O
110863,5,The,O
110863,5,patient,O
110863,5,received,O
110863,5,nebs,B-Drug
110863,5,prn,O
110863,5,.,O
110863,5,Patient,O
110863,5,further,O
110863,5,received,O
110863,5,Furosemide,B-Drug
110863,5,given,O
110863,5,concern,O
110863,5,for,O
110863,5,CHF,B-Reason
110863,5,on,O
110863,5,exam,O
110863,5,.,O
110863,5,Pt,O
110863,5,had,O
110863,5,one,O
110863,5,round,O
110863,5,of,O
110863,5,dialysis,O
110863,5,but,O
110863,5,did,O
110863,5,not,O
110863,5,resolve,O
110863,5,pt,O
110863,5,'s,O
110863,5,tachypnea,O
110863,5,.,O
110863,5,.,O
110863,5,#,O
110863,5,.,O
110863,5,Confusion,O
110863,5,:,O
110863,5,Not,O
110863,5,at,O
110863,5,home,O
110863,5,but,O
110863,5,started,O
110863,5,being,O
110863,5,delirious,O
110863,5,at,O
110863,5,[,O
110863,5,**Hospital1,O
110863,5,9487**,O
110863,5,],O
110863,5,.,O
110863,5,Might,O
110863,5,be,O
110863,5,due,O
110863,5,to,O
110863,5,hospitalization-related,O
110863,5,delirium,O
110863,5,in,O
110863,5,an,O
110863,5,elderly,O
110863,5,person,O
110863,5,",",O
110863,5,CHF,O
110863,5,exacerbation,O
110863,5,",",O
110863,5,pneumonia,O
110863,5,.,O
110863,5,Head,O
110863,5,bleed,O
110863,5,is,O
110863,5,a,O
110863,5,possible,O
110863,5,cause,O
110863,5,given,O
110863,5,thrombocytopenia,O
110863,5,.,O
110863,5,Uremia,O
110863,5,(,O
110863,5,urea,O
110863,5,>,O
110863,5,100,O
110863,5,),O
110863,5,from,O
110863,5,CKD,O
110863,5,was,O
110863,5,ultimately,O
110863,5,presumed,O
110863,5,to,O
110863,5,be,O
110863,5,the,O
110863,5,most,O
110863,5,likely,O
110863,5,cause,O
110863,5,.,O
110863,5,.,O
110863,5,#,O
110863,5,.,O
110863,5,HTN,B-Reason
110863,5,:,O
110863,5,Normotensive,O
110863,5,on,O
110863,5,admission,O
110863,5,.,O
110863,5,The,O
110863,5,patient,O
110863,5,was,O
110863,5,continued,O
110863,5,on,O
110863,5,Hydralazine,B-Drug
110863,5,",",O
110863,5,Labetolol,B-Drug
110863,5,and,O
110863,5,Ranolazine,B-Drug
110863,5,initially,O
110863,5,",",O
110863,5,though,O
110863,5,these,O
110863,5,meds,O
110863,5,were,O
110863,5,held,O
110863,5,for,O
110863,5,hypotension,O
110863,5,that,O
110863,5,may,O
110863,5,likely,O
110863,5,happen,O
110863,5,with,O
110863,5,dialysis,O
110863,5,.,O
110863,5,.,O
110863,5,#,O
110863,5,.,O
110863,5,Odynophagia,B-Reason
110863,5,:,O
110863,5,Was,O
110863,5,presumed,O
110863,5,due,O
110863,5,to,O
110863,5,mucositis,B-ADE
110863,5,from,O
110863,5,recent,O
110863,5,chemotherapy,B-Drug
110863,5,.,O
110863,5,Patient,O
110863,5,received,O
110863,5,pain,O
110863,5,control,O
110863,5,with,O
110863,5,narcotics,B-Drug
110863,5,and,O
110863,5,was,O
110863,5,monitored,O
110863,5,closely,O
110863,5,for,O
110863,5,thrush,O
110863,5,.,O
110863,5,Pt,O
110863,5,was,O
110863,5,also,O
110863,5,started,O
110863,5,on,O
110863,5,Fluc,B-Drug
110863,5,and,O
110863,5,Acyclovir,B-Drug
110863,5,.,O
110863,5,.,O
110863,5,#,O
110863,5,.,O
110863,5,CKD,O
110863,5,:,O
110863,5,Cr,O
110863,5,4.0,O
110863,5,at,O
110863,5,baseline,O
110863,5,but,O
110863,5,urea,O
110863,5,in,O
110863,5,the,O
110863,5,130s,O
110863,5,from,O
110863,5,the,O
110863,5,usual,O
110863,5,80s,O
110863,5,.,O
110863,5,The,O
110863,5,patient,O
110863,5,subsequently,O
110863,5,received,O
110863,5,one,O
110863,5,round,O
110863,5,of,O
110863,5,dialysis,O
110863,5,before,O
110863,6,his,O
110863,6,goals,O
110863,6,of,O
110863,6,care,O
110863,6,were,O
110863,6,changed,O
110863,6,.,O
110863,6,.,O
110863,6,#,O
110863,6,.,O
110863,6,Kaposi,O
110863,6,'s,O
110863,6,sarcoma,O
110863,6,with,O
110863,6,known,O
110863,6,visceral,O
110863,6,involvement,O
110863,6,:,O
110863,6,Patient,O
110863,6,was,O
110863,6,pancytopenic,B-Reason
110863,6,from,O
110863,6,recent,O
110863,6,chemotherapy,B-Drug
110863,6,.,O
110863,6,Pt,O
110863,6,was,O
110863,6,started,O
110863,6,on,O
110863,6,Neupogen,B-Drug
110863,6,and,O
110863,6,WBC,O
110863,6,responded,O
110863,6,appropriately,O
110863,6,.,O
110863,6,.,O
110863,6,#,O
110863,6,Pt,O
110863,6,was,O
110863,6,on,O
110863,6,pneumoboots,O
110863,6,for,O
110863,6,DVT,O
110863,6,ppx,O
110863,6,as,O
110863,6,pt,O
110863,6,had,O
110863,6,thrombocytopenia,O
110863,6,.,O
110863,6,Pt,O
110863,6,was,O
110863,6,DNR/DNI,O
110863,6,on,O
110863,6,admission,O
110863,6,",",O
110863,6,then,O
110863,6,made,O
110863,6,CMO,O
110863,6,in,O
110863,6,ICU,O
110863,6,.,O
110863,6,Pt,O
110863,6,was,O
110863,6,NPO,O
110863,6,given,O
110863,6,high,O
110863,6,risk,O
110863,6,of,O
110863,6,aspiration,O
110863,6,.,O
110863,6,Medications,O
110863,6,on,O
110863,6,Admission,O
110863,6,:,O
110863,6,MEDS,O
110863,6,ON,O
110863,6,TRANSFER,O
110863,6,:,O
110863,6,hydralazine,B-Drug
110863,6,25,O
110863,6,mg,O
110863,6,tid,O
110863,6,rosuvastatin,B-Drug
110863,6,40,O
110863,6,mg,O
110863,6,daily,O
110863,6,ferrous,B-Drug
110863,6,sulfate,I-Drug
110863,6,324,O
110863,6,mg,O
110863,6,daily,O
110863,6,fluconazole,B-Drug
110863,6,150,O
110863,6,mg,O
110863,6,IV,O
110863,6,daily,O
110863,6,Nephrocaps,B-Drug
110863,6,1,O
110863,6,capsule,O
110863,6,daily,O
110863,6,filgrastim,B-Drug
110863,6,300,O
110863,6,mcg,O
110863,6,SC,O
110863,6,daily,O
110863,6,nitroglycerin,B-Drug
110863,6,SL,O
110863,6,prn,O
110863,6,labetolol,B-Drug
110863,6,200,O
110863,6,mg,O
110863,6,[,O
110863,6,**Hospital1,O
110863,6,**,O
110863,6,],O
110863,6,famotidine,B-Drug
110863,6,20,O
110863,6,mg,O
110863,6,[,O
110863,6,**Hospital1,O
110863,6,**,O
110863,6,],O
110863,6,finasteride,B-Drug
110863,6,5,O
110863,6,mg,O
110863,6,daily,O
110863,6,ranolazine,B-Drug
110863,6,5,O
110863,6,mg,O
110863,6,daily,O
110863,6,calcitriol,B-Drug
110863,6,0.25,O
110863,6,mg,O
110863,6,daily,O
110863,6,vitamin,B-Drug
110863,6,D,I-Drug
110863,6,[,O
110863,6,**2097**,O
110863,6,],O
110863,6,units,O
110863,6,[,O
110863,6,**Hospital1,O
110863,6,**,O
110863,6,],O
110863,6,.,O
110863,6,MEDS,O
110863,6,AT,O
110863,6,HOME,O
110863,6,:,O
110863,6,ondansetron,B-Drug
110863,6,prn,O
110863,6,prochlorperazine,B-Drug
110863,6,prn,O
110863,6,furosemide,B-Drug
110863,6,80,O
110863,6,mg,O
110863,6,PO,O
110863,6,bid,O
110863,6,aspirin,B-Drug
110863,6,81,O
110863,6,mg,O
110863,6,daily,O
110863,6,labetalol,B-Drug
110863,6,200,O
110863,6,mg,O
110863,6,daily,O
110863,6,calcitriol,B-Drug
110863,6,0.25,O
110863,6,mcg,O
110863,6,daily,O
110863,6,cholecalciferol,B-Drug
110863,6,(,I-Drug
110863,6,vitamin,I-Drug
110863,6,D3,I-Drug
110863,6,),I-Drug
110863,6,"2,000",O
110863,6,unit,O
110863,6,daily,O
110863,6,atorvastatin,B-Drug
110863,6,80,O
110863,6,mg,O
110863,6,daily,O
110863,6,finasteride,B-Drug
110863,6,5,O
110863,6,mg,O
110863,6,daily,O
110863,6,ranolazine,B-Drug
110863,6,SR,O
110863,6,500,O
110863,6,mg,O
110863,6,daily,O
110863,6,ranitidine,B-Drug
110863,6,150,O
110863,6,mg,O
110863,6,qhs,O
110863,6,hydralazine,B-Drug
110863,6,25,O
110863,6,mg,O
110863,6,q8h,O
110863,6,epoetin,B-Drug
110863,6,alfa,I-Drug
110863,6,"10,000",O
110863,6,unit/mL,O
110863,6,1,O
110863,6,injection,O
110863,6,weekly,O
110863,6,clopidogrel,B-Drug
110863,6,75,O
110863,6,mg,O
110863,6,daily,O
110863,6,Renal,B-Drug
110863,6,Caps,I-Drug
110863,6,1,O
110863,6,mg,O
110863,6,Capsule,O
110863,6,daily,O
110863,6,Discharge,O
110863,6,Disposition,O
110863,6,:,O
110863,6,Expired,O
110863,6,Discharge,O
110863,6,Diagnosis,O
110863,6,:,O
110863,6,Kaposi,O
110863,6,'s,O
110863,6,sarcoma,O
110863,6,CHF,O
110863,6,ESRD,O
110863,6,Discharge,O
110863,6,Condition,O
110863,6,:,O
110863,6,expired,O
110863,6,Completed,O
110863,6,by,O
110863,6,:,O
110863,6,[,O
110863,6,**2108-12-16**,O
110863,6,],O
